These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15745341)

  • 1. [Secretory activity of the adipocytes and comorbidities of obesity].
    Skurk T; Hauner H
    MMW Fortschr Med; 2005 Jan; 147(4):41-3. PubMed ID: 15745341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Obesity and inflammation].
    Recasens M; Ricart W; Fernández-Real JM
    Rev Med Univ Navarra; 2004; 48(2):49-54. PubMed ID: 15382613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin and metabolic syndrome.
    Matsuzawa Y; Funahashi T; Kihara S; Shimomura I
    Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):29-33. PubMed ID: 14551151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of diet-induced weight loss on plasma apelin and cytokine levels in individuals with the metabolic syndrome.
    Heinonen MV; Laaksonen DE; Karhu T; Karhunen L; Laitinen T; Kainulainen S; Rissanen A; Niskanen L; Herzig KH
    Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):626-33. PubMed ID: 19278844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipokines in diabetes and cardiovascular diseases.
    Kralisch S; Sommer G; Deckert CM; Linke A; Bluher M; Stumvoll M; Fasshauer M
    Minerva Endocrinol; 2007 Sep; 32(3):161-71. PubMed ID: 17912155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
    Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
    Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adipose tissue: a multifunctional organ].
    Bon GB
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):23S-28S. PubMed ID: 18773748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin and its role in the obesity-induced insulin resistance and related complications.
    Haluzík M; Parízková J; Haluzík MM
    Physiol Res; 2004; 53(2):123-9. PubMed ID: 15046547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipocytokines and metabolic syndrome.
    Matsuzawa Y
    Semin Vasc Med; 2005 Feb; 5(1):34-9. PubMed ID: 15968578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin, the missing link in insulin resistance and obesity.
    Gil-Campos M; Cañete RR; Gil A
    Clin Nutr; 2004 Oct; 23(5):963-74. PubMed ID: 15380884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 diabetes and cardiovascular disease: getting to the fat of the matter.
    Goralski KB; Sinal CJ
    Can J Physiol Pharmacol; 2007 Jan; 85(1):113-32. PubMed ID: 17487251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin B2 deficiency enhances the pro-inflammatory activity of adipocyte, consequences for insulin resistance and metabolic syndrome development.
    Mazur-Bialy AI; Pocheć E
    Life Sci; 2017 Jun; 178():9-16. PubMed ID: 28414075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The delicate balance between fat and muscle: adipokines in metabolic disease and musculoskeletal inflammation.
    Nawrocki AR; Scherer PE
    Curr Opin Pharmacol; 2004 Jun; 4(3):281-9. PubMed ID: 15140421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overweight, hypertension and cardiovascular disease: focus on adipocytokines, insulin, weight changes and natriuretic peptides.
    Seven E
    Dan Med J; 2015 Nov; 62(11):B5163. PubMed ID: 26522487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The progression of cardiovascular risk to cardiovascular disease.
    Rosin BL
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S3-8. PubMed ID: 17934392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine and signalling role of adipose tissue: new perspectives on fat.
    Trayhurn P
    Acta Physiol Scand; 2005 Aug; 184(4):285-93. PubMed ID: 16026420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance and inflammation in the early phase of type 2 diabetes: potential for therapeutic intervention.
    Schernthaner GH; Schernthaner G
    Scand J Clin Lab Invest Suppl; 2005; 240():30-40. PubMed ID: 16112958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiotrophin-1 Regulates Adipokine Production in 3T3-L1 Adipocytes and Adipose Tissue From Obese Mice.
    López-Yoldi M; Marcos-Gomez B; Romero-Lozano MA; Sáinz N; Prieto J; Martínez JA; Bustos M; Moreno-Aliaga MJ
    J Cell Physiol; 2017 Sep; 232(9):2469-2477. PubMed ID: 27608275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.